Want to join the conversation?
$CSC 1Q16 PR: “We continue to target non-GAAP EPS (continuing operations) of $4.75-5.05 for FY16 and our free cash flow target remains unchanged at $750-800MM. As we continue to make good progress toward our planned separation later this year, we remain committed to serving our clients and investing where appropriate,” said Mike, CEO.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.